NEW YORK, Sept. 17 (GenomeWeb News) - An "emerging services sector" in India may benefit from a "new wave" of offshore contracts from the US pharmaceutical, biotech, and life sciences technology industries, according to a new market report.
The report, from New York-based Genomic Society Consulting, said that though the life science IT sector in the United Stateshas been slower than other sectors to turn to offshore outsourcing, several life science firms are currently working with bio-IT service providers in India.
"Salaries for skilled professionals and PhDs in this sector are as much as 90 percent lower in India than the US, so cost savings can be significant," Adrienne Burke, principal and author of the report, "India's Emerging Life Science IT Services Sector: Opportunities for Outsourcing, Partnership and Investment," said in a statement.
However, she added, "these offshore arrangements have shortcomings. They are not for every company or just any project."
Burke was a previous editor-in-chief of Genome Technology magazine, GenomeWeb News' sister publication.